icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Paris France
11-15 April 2018
Back grey_arrow_rt.gif
 
 
 
Clinical and virological characteristics of DAA-experienced patients with chronic HCV infection treated with sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX): results from the Frankfurt Resistance Database
 
 
  Reported by Jules Levin
EASL 2018 April 11-15 Paris France
 
Johannes Vermehren, Julia Dietz, Kai-Henrik Peiffer, Simone Susser, Stefan Zeuzem, Christoph Sarrazin Medizinische Klinik 1, Universitätsklinikum Frankfurt, Frankfurt am Main, Germany

0420181

0420182

0420183

0420184